10 drugs costing Medicare Part D the most

Medicare covered 30 percent of prescription drug costs, or $101 billion, in 2017, according to a new Kaiser Family Foundation study.

Advertisement

The 10 drugs costing Medicare the most:

1. Harvoni ($4.4 billion)
2. Revlimid ($2.6 billion)
3. Lantus Solostar ($2.5 billion)
4. Januvia ($2.4 billion)
5. Crestor ($2.3 billion)
6. Advair Diskus ($2.3 billion)
7. Lyrica ($2.1 billion)
8. Xarelto ($1.9 billion)
9. Eliquis ($1.9 billon)
10. Spiriva ($1.8 billion)

More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck’s Keytruda fails late-stage trial as standalone treatment for breast cancer

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.